# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013332
Filing Date
2022-05-13
Accepted
2022-05-13 16:16:35
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 920728
2 |  | ex31-1.htm | EX-31.1 | 11838
3 |  | ex31-2.htm | EX-31.2 | 11844
4 |  | ex32.htm | EX-32 | 9114
| Complete submission text file | 0001493152-22-013332.txt |  | 4795439

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | envb-20220331.xsd | EX-101.SCH | 38323
6 | XBRL CALCULATION FILE | envb-20220331_cal.xml | EX-101.CAL | 42498
7 | XBRL DEFINITION FILE | envb-20220331_def.xml | EX-101.DEF | 169981
8 | XBRL LABEL FILE | envb-20220331_lab.xml | EX-101.LAB | 342221
9 | XBRL PRESENTATION FILE | envb-20220331_pre.xml | EX-101.PRE | 255345
47 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 795616

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 22922929
SIC: 2834 Pharmaceutical Preparations